Text Size

Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00247871
First received: October 31, 2005
Last updated: September 28, 2011
Last verified: September 2011
History of Changes
  Purpose

We plan to compare data from 300 nasal swab in Vancouver's Downtown Eastside taken in 2001 to data obtained in 2005. The nasal carriage rate of MRSA and the specific characteristic of each MRSA found will be analyzed. A limited amount of associated information will be obtained


Condition
Nasal Colonization With MRSA Bacteria

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: The Prevalence of Panton Valentine Leukocidin, Exfoliative Toxin and Agr Genotypes in Staphylococcus Aureus Nasal Colonization in Vancouver's Eastside Community

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of British Columbia:

Estimated Enrollment: 600
Study Start Date: October 2005
Estimated Study Completion Date: December 2012
Detailed Description:

MRSA samples will be characterized by pulse field gel electropheresis. An 9 item questionnaire will be administered.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Vancouver's Downtown Eastside

Criteria

Inclusion Criteria:

Patient had a microbiological sample submitted from the emergency department of the study hospital from 2001- 2005 which grew MRSA.

Exclusion Criteria:

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00247871

Locations
Canada, British Columbia
Vancouver General Hospital
Vancouver, British Columbia, Canada
Sponsors and Collaborators
University of British Columbia
Investigators
Principal Investigator: Steve Reynolds, MD University of British Columbia
  More Information

No publications provided

Responsible Party: University of British Columbia
ClinicalTrials.gov Identifier: NCT00247871     History of Changes
Other Study ID Numbers: C05-0193
Study First Received: October 31, 2005
Last Updated: September 28, 2011
Health Authority: Canada: Health Canada

Keywords provided by University of British Columbia:
MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses

Additional relevant MeSH terms:
Staphylococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on May 22, 2013